ZAP70
Basic information
Region (hg38): 2:97713576-97744327
Previous symbols: [ "SRK" ]
Links
Phenotypes
GenCC
Source:
- combined immunodeficiency due to ZAP70 deficiency (Supportive), mode of inheritance: AR
- combined immunodeficiency due to ZAP70 deficiency (Strong), mode of inheritance: AR
- combined immunodeficiency due to ZAP70 deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Autoimmune disease, multisystem, infantile-onset 2; Immunodeficiency 48 | AR | Allergy/Immunology/Infectious | In Autoimmune disease, multisystem, infantile-onset 2, individuals may demonstrate multiple autoimmune sequelae that may be refractory to immunosuppressants, and HSCT has been described as effective; In Selective T-cell defect, prophylactic measures, in the short term, include IVIG administration as well as antiinfectious prophylaxis; If blood products are necessary, they should be irradiated and CMV and EBV-negative; Live vaccines should be avoided, and immunizations should be deferred until reconstitution of the immune system; HSCT has been described as effective in some individuals | Allergy/Immunology/Infectious | 2511270; 8124727; 8202713; 8202712; 10574909; 10748099; 11123350; 11412303; 11463783; 18509675; 19548248; 20301777; 23124046; 26783323 |
ClinVar
This is a list of variants' phenotypes submitted to
- ZAP70-Related Severe Combined Immunodeficiency (10 variants)
- not provided (3 variants)
- Combined immunodeficiency due to ZAP70 deficiency (3 variants)
- Combined immunodeficiency (2 variants)
- Autoimmune disease, multisystem, infantile-onset, 2 (1 variants)
- ZAP70-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZAP70 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 127 | 135 | ||||
missense | 151 | 160 | ||||
nonsense | 10 | |||||
start loss | 1 | |||||
frameshift | 5 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 15 | 13 | 28 | |||
non coding | 12 | 56 | 21 | 92 | ||
Total | 15 | 7 | 169 | 187 | 27 |
Highest pathogenic variant AF is 0.0000131
Variants in ZAP70
This is a list of pathogenic ClinVar variants found in the ZAP70 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-97713589-C-A | Combined immunodeficiency due to ZAP70 deficiency • not specified | Benign (Jan 24, 2024) | ||
2-97713598-C-A | Combined immunodeficiency due to ZAP70 deficiency | Likely benign (Jan 13, 2018) | ||
2-97713642-C-T | Combined immunodeficiency due to ZAP70 deficiency | Uncertain significance (Jan 12, 2018) | ||
2-97713755-A-G | not specified | Benign (Jan 24, 2024) | ||
2-97713815-TGTGTGCGG-T | Benign (Jul 15, 2021) | |||
2-97713902-G-A | not specified | Likely benign (May 25, 2017) | ||
2-97713925-T-A | Combined immunodeficiency due to ZAP70 deficiency | Benign (Jan 13, 2018) | ||
2-97713935-T-G | Severe combined immunodeficiency disease | Uncertain significance (Jun 14, 2016) | ||
2-97713957-T-C | Combined immunodeficiency due to ZAP70 deficiency | Benign (Jan 13, 2018) | ||
2-97723901-A-C | not specified | Benign (Nov 12, 2023) | ||
2-97724039-G-T | Uncertain significance (Sep 16, 2018) | |||
2-97724043-G-C | ZAP70-Related Severe Combined Immunodeficiency | Uncertain significance (Nov 06, 2018) | ||
2-97724052-G-A | ZAP70-Related Severe Combined Immunodeficiency | Uncertain significance (Aug 18, 2019) | ||
2-97724053-C-T | ZAP70-Related Severe Combined Immunodeficiency | Uncertain significance (Apr 04, 2023) | ||
2-97724057-C-G | ZAP70-Related Severe Combined Immunodeficiency | Uncertain significance (Dec 29, 2021) | ||
2-97724061-C-G | ZAP70-Related Severe Combined Immunodeficiency | Uncertain significance (Nov 08, 2022) | ||
2-97724073-G-C | ZAP70-Related Severe Combined Immunodeficiency | Uncertain significance (Nov 16, 2020) | ||
2-97724073-G-T | Inborn genetic diseases | Uncertain significance (Apr 28, 2023) | ||
2-97724082-T-C | ZAP70-Related Severe Combined Immunodeficiency | Uncertain significance (Jun 26, 2020) | ||
2-97724084-G-A | ZAP70-Related Severe Combined Immunodeficiency | Likely benign (Oct 18, 2022) | ||
2-97724084-G-C | ZAP70-Related Severe Combined Immunodeficiency | Likely benign (Oct 05, 2022) | ||
2-97724086-G-T | ZAP70-Related Severe Combined Immunodeficiency | Uncertain significance (Dec 27, 2021) | ||
2-97724116-C-A | ZAP70-Related Severe Combined Immunodeficiency • Combined immunodeficiency due to ZAP70 deficiency | Uncertain significance (Sep 02, 2021) | ||
2-97724117-G-A | ZAP70-Related Severe Combined Immunodeficiency | Likely benign (Jan 13, 2023) | ||
2-97724126-G-A | ZAP70-Related Severe Combined Immunodeficiency | Likely benign (Aug 30, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ZAP70 | protein_coding | protein_coding | ENST00000264972 | 12 | 26303 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.877 | 0.123 | 125730 | 0 | 14 | 125744 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.76 | 257 | 415 | 0.619 | 0.0000300 | 4010 |
Missense in Polyphen | 97 | 190.4 | 0.50945 | 1794 | ||
Synonymous | 1.09 | 168 | 187 | 0.899 | 0.0000156 | 1186 |
Loss of Function | 4.11 | 5 | 28.8 | 0.173 | 0.00000141 | 329 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000120 | 0.000119 |
Ashkenazi Jewish | 0.000198 | 0.000198 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000557 | 0.0000527 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000671 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates motility, adhesion and cytokine expression of mature T-cells, as well as thymocyte development. Contributes also to the development and activation of primary B-lymphocytes. When antigen presenting cells (APC) activate T-cell receptor (TCR), a serie of phosphorylations lead to the recruitment of ZAP70 to the doubly phosphorylated TCR component CD247/CD3Z through ITAM motif at the plasma membrane. This recruitment serves to localization to the stimulated TCR and to relieve its autoinhibited conformation. Release of ZAP70 active conformation is further stabilized by phosphorylation mediated by LCK. Subsequently, ZAP70 phosphorylates at least 2 essential adapter proteins: LAT and LCP2. In turn, a large number of signaling molecules are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation. Furthermore, ZAP70 controls cytoskeleton modifications, adhesion and mobility of T-lymphocytes, thus ensuring correct delivery of effectors to the APC. ZAP70 is also required for TCR-CD247/CD3Z internalization and degradation through interaction with the E3 ubiquitin-protein ligase CBL and adapter proteins SLA and SLA2. Thus, ZAP70 regulates both T-cell activation switch on and switch off by modulating TCR expression at the T-cell surface. During thymocyte development, ZAP70 promotes survival and cell-cycle progression of developing thymocytes before positive selection (when cells are still CD4/CD8 double negative). Additionally, ZAP70-dependent signaling pathway may also contribute to primary B-cells formation and activation through B-cell receptor (BCR). {ECO:0000269|PubMed:11353765, ECO:0000269|PubMed:12051764, ECO:0000269|PubMed:1423621, ECO:0000269|PubMed:20135127, ECO:0000269|PubMed:26903241, ECO:0000269|PubMed:8124727, ECO:0000269|PubMed:8702662, ECO:0000269|PubMed:9489702}.;
- Disease
- DISEASE: Immunodeficiency 48 (IMD48) [MIM:269840]: A form of severe immunodeficiency characterized by a selective absence of CD8+ T-cells. {ECO:0000269|PubMed:11123350, ECO:0000269|PubMed:11412303, ECO:0000269|PubMed:18509675, ECO:0000269|PubMed:8124727, ECO:0000269|PubMed:8202713}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Autoimmune disease, multisystem, infantile-onset, 2 (ADMIO2) [MIM:617006]: An autosomal recessive, autoimmune disorder characterized by systemic manifestations including blistering skin disease, uncontrollable bullous pemphigoid, inflammatory colitis, autoimmune hypothyroidism, proteinuria and nephrotic syndrome. {ECO:0000269|PubMed:26783323}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Primary immunodeficiency - Homo sapiens (human);T cell receptor signaling pathway - Homo sapiens (human);Th17 cell differentiation - Homo sapiens (human);Th1 and Th2 cell differentiation - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);Natural killer cell mediated cytotoxicity - Homo sapiens (human);NF-kappa B signaling pathway - Homo sapiens (human);Prolactin Signaling Pathway;T-Cell Receptor and Co-stimulatory Signaling;JAK-STAT;T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection;Ras Signaling;Inflammatory Response Pathway;Interferon type I signaling pathways;T-Cell antigen Receptor (TCR) Signaling Pathway;lck and fyn tyrosine kinases in initiation of tcr activation;role of mef2d in t-cell apoptosis;activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor;t cell receptor signaling pathway;Prolactin;Generation of second messenger molecules;Translocation of ZAP-70 to Immunological synapse;TCR signaling;CD4 T cell receptor signaling-ERK cascade;TCR;Immune System;Adaptive Immune System;BCR;IL-7 signaling;JAK STAT pathway and regulation;EPO signaling;Class I PI3K signaling events;VEGF;TCR signaling in naïve CD8+ T cells;TCR signaling in naïve CD4+ T cells;CD4 T cell receptor signaling-JNK cascade;CD4 T cell receptor signaling-NFkB cascade;CD4 T cell receptor signaling
(Consensus)
Recessive Scores
- pRec
- 0.629
Intolerance Scores
- loftool
- 0.0533
- rvis_EVS
- -1.16
- rvis_percentile_EVS
- 6.17
Haploinsufficiency Scores
- pHI
- 0.393
- hipred
- Y
- hipred_score
- 0.793
- ghis
- 0.574
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.858
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zap70
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; cellular phenotype; immune system phenotype; skeleton phenotype; respiratory system phenotype; normal phenotype; hematopoietic system phenotype;
Zebrafish Information Network
- Gene name
- zap70
- Affected structure
- pro-T cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- adaptive immune response;protein phosphorylation;immune response;peptidyl-tyrosine phosphorylation;T cell differentiation;intracellular signal transduction;T cell activation;B cell activation;beta selection;positive thymic T cell selection;negative thymic T cell selection;positive regulation of T cell differentiation;positive regulation of alpha-beta T cell differentiation;positive regulation of alpha-beta T cell proliferation;protein autophosphorylation;positive regulation of calcium-mediated signaling;T cell receptor signaling pathway;T cell aggregation;T cell migration
- Cellular component
- immunological synapse;cytoplasm;cytosol;plasma membrane;cell-cell junction;T cell receptor complex;membrane raft
- Molecular function
- phosphotyrosine residue binding;protein tyrosine kinase activity;non-membrane spanning protein tyrosine kinase activity;protein binding;ATP binding